MANILA — The Philippines has given full emergency use authorization to the COVID-19 vaccine made by India's Bharat Biotech, paving the way for the importation of the shots, the Food and Drug Administration said on Friday.
Bharat last week submitted a certificate for good manufacturing practices, completing requirements for the import of its COVID-19 shot called Covaxin, said FDA chief Eric Domingo.
"Ngayon maaari na po silang mag-import. Maaari na pong gamitin din dito sa bansa po natin," he said in a televised public briefing.
(They can now import. It can now be used here in our country.)
Bharat estimates it can make 23 million doses a month.
Earlier this week, television channel CNBC-TV18 reported that phase-3 data for Covaxin showed an efficacy of 77.8 percent.
Bharat said its vaccine pricing had been consistently at $15-$20 per dose for foreign governments, a range in which the Brazil contract fell.
The Philippines has cleared for emergency use COVID-19 vaccines from Pfizer-BioNTech, Britain's AstraZeneca, Beijing-based Sinovac Biotech, Russian Gamaleya Institute, Johnson & Johnson, and Moderna.
Among the hardest hit by the COVID-19 pandemic in Asia, the Philippines has received at least 16.2 million coronavirus vaccine doses, of which some 8.9 million have been administered.
– With reports from Jamaine Punzalan, ABS-CBN News; Reuters